Lack of soluble circulating cardiodepressant factors in takotsubo cardiomyopathy
- 1 December 2017
- journal article
- research article
- Published by Elsevier in Autonomic Neuroscience
- Vol. 208, 170-172
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Clinical Features and Outcomes of Takotsubo (Stress) CardiomyopathyNew England Journal of Medicine, 2015
- Neurogenic Stunned Myocardium Following Acute Subarachnoid HemorrhageJournal of Intensive Care Medicine, 2013
- In-hospital mortality among patients with takotsubo cardiomyopathy: A study of the National Inpatient Sample 2008 to 2009American Heart Journal, 2012
- Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart FailurePLOS ONE, 2012
- Proposed Mayo Clinic criteria for the diagnosis of Tako-Tsubo cardiomyopathy and long-term prognosisHerz, 2010
- Stress hormone and circulating biomarker profile of apical ballooning syndrome (Takotsubo cardiomyopathy): insights into the clinical significance of B-type natriuretic peptide and troponin levelsHeart, 2009
- Importance of Inflammation and Neurohumoral Activation in Takotsubo CardiomyopathyJournal of Cardiac Failure, 2009
- Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional StressNew England Journal of Medicine, 2005
- Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.Journal of Experimental Medicine, 1996
- A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.Journal of Clinical Investigation, 1985